Springfield, MO3 Active Studies

Leukemia Clinical Trials in Springfield, MO

Find 3 actively recruiting leukemia clinical trials in Springfield, MO. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
1,815
Enrolling

Recruiting Leukemia Studies in Springfield

RecruitingSpringfield, MONCT06801834

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated ex...

695 participants
Gilead Sciences
View Study Details
RecruitingSpringfield, MONCT06345729

A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

This is a study evaluating the efficacy and safety of MK-1084 with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ide...

600 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingSpringfield, MONCT06305754

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squ...

520 participants
Merck Sharp & Dohme LLC
View Study Details

About Leukemia Clinical Trials in Springfield

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 3 leukemia clinical trials recruiting participants in Springfield, MO. These studies are seeking a combined 1,815 participants. Research is being sponsored by Gilead Sciences, Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Springfield — FAQ

Are there leukemia clinical trials in Springfield?

Yes, there are 3 leukemia clinical trials currently recruiting in Springfield, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Springfield?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Springfield research site will contact you about next steps.

Are clinical trials in Springfield free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Springfield studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 3 active trials in Springfield are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov